Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus
about
Antiviral perspectives for chikungunya virusNovel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanismProduction of Chikungunya Virus-Like Particles and Subunit Vaccines in Insect CellsCross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccineChikungunya virus infectionProbing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signalingA virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infectionDNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in miceEnvelope specific T cell responses & cytokine profiles in chikungunya patients hospitalized with different clinical presentationsPrime-boost immunization strategies against Chikungunya virusChikungunya vaccines in developmentMolecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccinationFingolimod treatment abrogates chikungunya virus–induced arthralgiaHLA class II allele polymorphism in an outbreak of chikungunya fever in Middle Andaman, IndiaA chikungunya fever vaccine utilizing an insect-specific virus platformAnimal Models of Chikungunya Virus Infection and Disease.Next generation sequencing of DNA-launched Chikungunya vaccine virus.Chikungunya: a potentially emerging epidemic?A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primatesProtection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin.A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in miceOptimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.Chikungunya virus arthritis in adult wild-type mice.Characterization of chikungunya virus-like particles.Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizationsEffective chikungunya virus-like particle vaccine produced in insect cells.A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritisHIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivoEnhanced production of Chikungunya virus-like particles using a high-pH adapted spodoptera frugiperda insect cell line.Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity.Do we need a vaccine against chikungunya?Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45Addressing viral resistance through vaccinesA chimeric vesiculo/alphavirus is an effective alphavirus vaccineInactivation of Chikungunya virus by 1,5 iodonapthyl azide.Chikungunya virus and prospects for a vaccine.
P2860
Q21284682-B1C1D992-4C74-4DCD-8757-3A100FC2C803Q21559402-C9502D29-FD23-492B-9FBC-D09A7E37430BQ24261442-809507E3-6CC0-490D-B5FD-E31A34D10352Q24276414-7767A164-E2D6-42C5-98BE-E7C34FF34833Q24497757-5A847BD6-C7E2-490D-838B-6AB8D1BCB1AFQ24608725-40B90121-2AAE-4DDA-BA18-95ED254C4774Q24631774-86E5C8AA-7A46-410A-B52B-541E34A7487BQ24701765-AAD9D76D-E571-4D8A-A4F6-A226921E432DQ24701768-71351032-5F2C-4D3C-BEBC-82E6366B8DE6Q24701774-98F1BC1A-18CA-47F1-A87B-1B00D2E9E181Q26700081-60D9CA75-0E46-4EC3-914F-B39AFBA0FE2DQ28236770-34B89ED3-C4A9-4857-9084-63F16DF7A39DQ28656413-E53401F7-D1AC-4D9B-A846-CE6792779220Q28678706-0351557D-0F27-4EF7-8C68-01E18E869E19Q28954709-F8395EDF-FE47-42DC-87FC-A3F10DF86756Q30240216-CDAD654D-5BDB-49C1-AC0C-646B803534A0Q30384231-4597CC0B-9335-419B-A34E-0C8AC1CDC476Q30388754-9586AD09-A142-4A17-A89B-C25FD0CBD91CQ30398956-19DF585F-1DE1-4EF8-9513-3F9CB5A0A220Q30401519-4218AC88-796D-4797-BB50-FEB67FF0F3A6Q30938741-2C443C1F-C2B0-4B0E-AEC9-88D458367E5BQ33586294-D80DBBCB-DA63-45E2-BE75-85ADFF70F947Q33684369-2D7C9EA3-0EF5-4FCD-BB6E-BC51D61984C8Q34046030-8519CA0D-B509-47B5-9C87-2EB1700A43EAQ34268026-3716D710-6371-4AF0-A8F2-3BDB258BC912Q34394530-BA574304-E1FA-4A3C-9175-AD90D4C92092Q34593874-C6AA0FF8-8F6C-4304-9E00-D1846E5ABA60Q34630576-02EF7CA6-A99F-48E0-BC0B-65B7DA5BFED9Q34703785-7BB3EE9C-0A7F-4464-B6CB-A229F58A6196Q35082880-2D2C0948-5A90-4FCB-9BFD-1E2B3344EB42Q35142715-2C4AC69C-421E-40EE-AF1A-C81162520F58Q35238179-C8A9696C-60BB-46CE-A5A7-5B5FDB821072Q35399263-039576B0-31E8-4C97-B153-EEC0428A67B0Q35826774-B7E727FB-48A0-4EBC-9763-2389C925C4ABQ35933249-6166CE86-A23D-4A2D-B888-7515ED29778DQ36256428-2A64CE30-52D0-4EBE-8D7D-441782B691CAQ36304783-BA288DF4-EFEB-46EA-9459-4B83193AB10EQ36506753-3A7E882C-654F-4051-96BC-2CCC3867F890Q36535622-3452617F-0685-4865-B6CB-6FD089C1DD3BQ36582816-5A45B8FC-6592-4BD6-92FE-D6FA00ECD319
P2860
Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus
@ast
Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus
@en
Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus
@nl
type
label
Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus
@ast
Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus
@en
Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus
@nl
prefLabel
Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus
@ast
Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus
@en
Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus
@nl
P2093
P2860
P1433
P1476
Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus
@en
P2093
Christopher W Chung
David B Weiner
Dominick J Laddy
Joseph J Kim
Katthikbabu M Lankaraman
Paluru Vijayachari
Senthil G Sundaram
P2860
P304
P356
10.1016/J.VACCINE.2008.03.060
P407
P5008
P577
2008-09-19T00:00:00Z